Related Experiment Videos
Lymphocyte transformation test in veterinary clinical immunology
Comparative Immunology, Microbiology and Infectious Diseases
|January 1, 1981
Summary
The lymphocyte transformation test assesses animal immune competence by measuring lymphocyte response to mitogens. This test helps detect impaired lymphocyte function or immunosuppressive factors in serum, aiding in disease diagnosis.
Area of Science:
- Veterinary Immunology
- Laboratory Animal Science
Background:
- The lymphocyte transformation test (LTT) is crucial for evaluating animal immunologic competence.
- Assessing lymphocyte function and identifying mitogenesis-suppressing factors in serum are key diagnostic challenges.
Purpose of the Study:
- To detail the methodology and interpretation of the LTT for assessing animal immune status.
- To highlight the utility of LTT in detecting impaired lymphocyte function and serum-based immunosuppression in animals.
Main Methods:
- Utilized lymphocyte transformation measured by thymidine incorporation in media with autologous, homologous, or fetal calf serum.
- Employed multiple phytomitogens (concanavalin A, pokeweed mitogen, phytohemagglutinin) at optimal and decreased concentrations.
- Analyzed background counts and stimulation indexes (SI) in various animal species.
Main Results:
- Optimal results achieved using at least two, preferably three, phytomitogens.
- Established baseline background counts and stimulation indexes for healthy dogs, cattle, and horses.
- Correlated increased background counts with viral infections and lymphoreticular disorders; decreased counts with various diseases.
- Observed increased SI during disease incubation and decreased SI linked to immunosuppressive factors, reduced lymphocyte responsiveness, or unidentified serum factors.
Conclusions:
- The LTT is a valuable tool for diagnosing immunologic disorders in animals.
- Specific patterns of background counts and stimulation indexes can indicate different disease states and underlying causes of immune dysfunction.